State-by-State Prior Auth Reform: Where We Stand in 2024

The frustration with prior authorization has reached a tipping point in state legislatures across the country. While federal reform has moved slowly, states have stepped in with a growing body of legislation aimed at reducing the prior authorization burden on physicians and improving patient access to care. The result is a patchwork of reforms that varies significantly from state to state — and that every practice owner and office manager needs to understand.

The Gold Card Movement

Texas made national headlines in 2021 when it passed HB 3459, commonly known as the "gold card" law. The concept is straightforward: physicians who demonstrate a high approval rate for prior authorization requests in a given category should be exempt from the requirement in that category going forward. Under the Texas law, if a physician has a 90% or higher approval rate for a specific service over a six-month period, the payer must exempt that physician from prior authorization for that service.

The gold card approach appeals to both sides of the debate. Payers retain the ability to review utilization for physicians who do not meet the threshold, while high-performing physicians are freed from a process that adds cost and delay without meaningfully changing prescribing patterns. Several states have followed Texas's lead with their own versions of gold card legislation, though the specific thresholds and implementation details vary.

West Virginia, Louisiana, and Michigan have all enacted or advanced gold card provisions. Some states have set the approval threshold at 80% rather than 90%, and others have varied the look-back period or the scope of services covered. The details matter — a gold card law with a 95% threshold and a narrow scope of covered services may provide less relief than a law with an 80% threshold applied broadly.

Response Time Requirements

Another major category of state reform focuses on how quickly payers must respond to prior authorization requests. The traditional model — where payers could take days or even weeks to respond to a non-urgent request — created cascading delays that harmed patients and complicated practice scheduling.

Multiple states have now enacted laws requiring payers to respond to prior authorization requests within specific timeframes. Common provisions include:

• Urgent requests: 24 to 48 hours, reflecting the clinical reality that some treatments cannot wait.
• Standard requests: 3 to 7 business days, depending on the state. Some states have pushed for even shorter windows.
• Automatic approval: If the payer fails to respond within the required timeframe, the request is deemed approved. This "silence means yes" provision is perhaps the most impactful reform for practices, as it eliminates the open-ended waiting that consumes staff time.

States including Arkansas, Illinois, and North Carolina have enacted versions of these timeline requirements. The automatic approval provision is particularly significant because it shifts the burden of timely processing from the practice to the payer — if the payer does not act, the authorization is granted.

Transparency and Reporting Requirements

A third wave of state reform focuses on transparency. Several states now require payers to publicly report data on their prior authorization activities, including the number of requests received, approval and denial rates, average response times, and the most commonly denied services. This data serves multiple purposes: it allows regulators to identify payers with outlier denial patterns, it gives practices insight into which payers are most burdensome, and it creates public accountability.

Oregon and Colorado have been leaders in transparency legislation. Oregon's law requires payers to report prior authorization metrics annually to the state's Department of Consumer and Business Services. Colorado has enacted similar provisions as part of broader healthcare transparency legislation. When this data is available, practices can make more informed decisions about payer contracts and can allocate prior authorization resources based on actual payer behavior rather than anecdote.

Continuity of Care Protections

Some states have addressed a particularly harmful aspect of prior authorization: the mid-treatment disruption. When a patient is stable on a medication or in the middle of a treatment course, a payer's decision to change prior authorization requirements can force the patient to switch therapies or interrupt treatment. Several states have enacted continuity of care protections that prohibit payers from imposing new prior authorization requirements on patients who are already receiving an approved treatment.

These protections are especially important for patients on specialty medications where stability on a specific therapy is clinically significant. Switching a patient from one biologic to another solely because of a formulary change can result in disease flares, loss of response, and the need to restart a complex titration process. Continuity of care laws recognize that prior authorization should not override clinical judgment when a patient is responding to an established treatment plan.

The Limits of State-Level Reform

While state reforms have made meaningful progress, they come with inherent limitations. The most significant is the ERISA preemption issue. The Employee Retirement Income Security Act of 1974 governs self-funded employer health plans, which cover roughly 65% of workers with employer-sponsored insurance. State insurance laws generally do not apply to ERISA-governed plans, which means that a large portion of the commercially insured population may not benefit from state-level prior authorization reforms.

This creates an uneven landscape for practices. A gold card exemption may apply to a patient covered by a fully insured plan regulated by the state, but not to a patient whose employer self-funds through the same insurance company. Practices must navigate these distinctions, which adds complexity rather than reducing it.

Additionally, enforcement varies widely. A law on the books is only as effective as its enforcement mechanism. Some states have robust regulatory frameworks and active oversight of payer compliance, while others have passed reform legislation without allocating sufficient resources for enforcement. Practices in states with strong reform laws may still encounter payers that do not fully comply, and the process of filing a regulatory complaint is itself time-consuming.

What Practices Should Track

For practice owners and office managers, staying current on state prior authorization reform is not optional — it is an operational necessity. Key questions to monitor include:

1. Has your state enacted gold card or automatic exemption legislation? If so, what are the specific thresholds and which services are covered?
2. Are there mandated response timeframes for prior authorization requests in your state? Do they include automatic approval provisions for payer non-response?
3. Does your state require payer transparency reporting on prior authorization metrics? If so, where can you access this data?
4. Are there continuity of care protections that prevent mid-treatment prior authorization changes?
5. How does ERISA preemption affect the applicability of your state's reforms to your patient population?

The Federal Horizon

State reform is happening alongside federal activity, most notably the CMS Interoperability and Prior Authorization Final Rule published in January 2024. While the federal rule primarily applies to Medicare Advantage, Medicaid, and plans on the federal exchange, it establishes standards and expectations that are likely to influence commercial payer behavior over time.

The combination of state-level innovation and federal rulemaking is creating momentum for meaningful change in how prior authorization works. For practices, the practical implication is clear: understand your state's current laws, track pending legislation, and ensure that your prior authorization processes are designed to take advantage of any available exemptions or protections. The reform landscape is moving — and practices that stay informed will be positioned to benefit.